Clinical Trials Browser

Phase 2 × Rhabdomyosarcoma × Ifosfamide × Clear all

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Phase 2 Active not recruiting

Rhabdomyosarcoma

NCT01055314 2017-08-29

Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Phase 2 Completed

175 enrolled 13 charts

Rhabdomyosarcoma, Sarcoma

NCT00003292 2013-11-08

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Phase 2 Terminated

Chondrosarcoma, Fibrosarcoma, Leiomyosarcoma, Meningioma, Rhabdomyosarcoma